Sanofi SA vs Stanley Black & Decker, Inc. — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while Stanley Black & Decker, Inc. trades at $87.62 (market cap $13.60B). The key difference: Sanofi SA is far larger — about 7.7× Stanley Black & Decker, Inc.'s market cap, and Sanofi SA pays the higher dividend (5.5%). Which is the better fit depends on your goals.
| SNY | SWK | |
|---|---|---|
Market Cap | $104.83B | $13.60B |
Sector | Health | — |
52-Week High | $52.34 | $94.12 |
52-Week Low | $41.33 | $62.12 |
Enterprise Value | $121.32B | $19.77B |
Dividend Yield | 5.5% | 3.79% |
Trailing returns across standard periods
Latest headlines on both assets
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates three business segments: tools and storage, security, and industrial. Tools and storage, the largest segment by revenue, sells hand tools and power tools to professional end-users, distributors, retail consumers, and industrial customers. Security installs electronic security systems and provides electronic security services including alarm monitoring and video surveillance. Industrial sells engineered fastening products such as stud-welding systems, blind inserts and tools, and engineered plastic and mechanical fasteners. The largest end market is the United States of America.
Read more on SWK →